SCHEMBL26257708

SCHEMBL26257708

COCc1ccc2ccccc2c1-c1c(COC)ccc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
ALDH1A1 P00352 2/20 0.42
CYP2A6 P11509 2/20 0.42
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
ALOX12 P18054 1/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPRT1 P00492 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ATM Q13315 1/20 0.38
CYP1A2 P05177 1/20 0.38
NISCH Q9Y2I1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5744984 0.84 MAPT (0.42) MAPTALDH1A1HSD17B10TDP1RAB9A
SCHEMBL736665 0.82 HSD17B10 (0.41) MAPTALDH1A1CYP2A6TSHRHSD17B10
SCHEMBL14591514 0.82 TSHR (0.50) MAPTALDH1A1CYP2A6TSHRHSD17B10
SCHEMBL6961971 0.81 POLB (0.46) MAPTALDH1A1CYP2A6TSHRHSD17B10
SCHEMBL2222086 0.81 PTPN22 (0.53)
SCHEMBL20020372 0.81 MAPT (0.40) MAPTALDH1A1CYP2A6TSHRHSD17B10
SCHEMBL11893039 0.79 NCEH1 (0.44) MAPTALDH1A1CYP2A6TSHRHSD17B10
SCHEMBL792004 0.79 CYP1A2 (0.53) TDP1RAB9ANPC1MEN1KMT2A
SCHEMBL11314967 0.78 KDM4E (0.52) MAPTALDH1A1TDP1RAB9AKDM4E
SCHEMBL30219496 0.78 HSD17B10 (0.38) MAPTALDH1A1CYP2A6TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760712-B2 Triarylmethane compounds MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760712-B2 Triarylmethane compounds CBR3, HAX1, HRH3 MAPT 4486/4885ALDH1A1 2431/4885CYP2A6 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.